Skip to main content

AusPAR: Spevigo

Australian Public Assessment Report
Device/Product Name
Spevigo
Active ingredients
Spesolimab
AusPAR Date
Published
Submission Number
PM-2022-01272-1-1
Submission Type
New biological entity
Decision
Approved

Help us improve this page

This form is anonymous. If you would like a response from us, please visit Contact us.